Inflammation and advanced glycation end products in uremia: Simple coexistence, potentiation or causal relationship?

Kidney International, Supplement

Volumn 59, Issue 78, 2001, Pages S32-S36

  Schwedler, Susanne ^a,b,c   Schinzel, Reninhard ^a,c   Vaith, Peter ^a,c   Wanner, Christoph ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Biocenter ^*

Author keywords

Acute phase response; C reactive protein; Cardiovascular disease; Hepatocytes; Monocytes; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; AUTACOID; C REACTIVE PROTEIN; CYTOKINE; IMMUNOGLOBULIN RECEPTOR; ACUTE PHASE PROTEIN; ANTIOXIDANT; APOLIPOPROTEIN; CELL ADHESION MOLECULE; COMPLEMENT; FIBRINOGEN; OXIDIZING AGENT; SERUM AMYLOID A;

ACUTE PHASE RESPONSE; HUMAN; INFLAMMATION; METABOLISM; REVIEW; UREMIA; AORTA; ATHEROSCLEROSIS; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DISEASE MARKER; ENDOTHELIUM CELL; HEMODIALYSIS PATIENT; LIPID METABOLISM; PRIORITY JOURNAL;

ACUTE-PHASE REACTION; C-REACTIVE PROTEIN; CYTOKINES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; RECEPTORS, IMMUNOLOGIC; UREMIA;

EID: 0035130252     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.59780032.x     Document Type: Article

References (57)

1. The chemistry of the Maillard reaction under physiological conditions
2. Perspectives in diabetes. Role of oxidative stress in diabetic complications. A new perspective of an old paradigm
3. Pathway of formation of glycoxidation during glycation of collagen
4. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs
5. Effects of kidney or kidney-pancreas transplantation on plasma pentosidine
6. Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells
7. Advanced glycosylation end products in patients with diabetic nephropathy
8. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications
9. Quantitation of 3-deoxyglucosone levels in human plasma
10. Elevated serum levels of 3-deoxyglucosone, a potent protein-cross-linking intermediate of the Maillard reaction, in uremic patients
11. Chronic renal failure - A vasculopathic state
12. Report on the management of renal failure in Europe, XXII, 1991
13. The clinical epidemiology of cardiac disease in chronic renal failure
14. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure
15. Immunohistochemical study of human advanced glycation end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation
16. Immunohistochemical detection of imidazolone and N (Carboxymethyl)lysine in aortas of hemodialysis patients
17. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes
18. Receptors for advanced glycation end-products (AGE)-expression by endothelial cells in non-diabetic uraemic patients
19. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
20. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
21. Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients
22. Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: A prospective study in 412 subjects
23. Fibrinogen coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipids as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients
24. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: Effects of hemodialysis
25. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
26. Fibrinogen: Its emerging role as a cardiovascular risk factor
27. Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group
28. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
29. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European concerted action on thrombosis and disabilities angina pectoris study group
30. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the cardiovascular health study and the rural health promotion project
31. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
32. Complement and atherogenesis: Binding of CRP to degraded, nonoxidized LDL enhances complement activation
33. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
34. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion
35. Recombinant human interleukin 6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes
36. Interleukin- 6 is the major regulator of acute phase protein synthesis in adult human hepatocytes
37. Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6
38. Interferon alpha2/BSF-2 shares identity with monocyte derived hepatocyte stimulating factor (HSF) and regulates the major acute phase protein response in liver cells
39. Cell-free-synthesized interleukin-6 (BSF-2/IFN-gamma 2) exhibits hepatocyte-stimulating activity
40. Immune system dysregulation in uremia
41. Elevated circulating levels of interleukin-6 in patients with chronic renal failure
42. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro
43. Cachectin/TNF and IL1 induced by glucose-modified proteins: Role in normal tissue remodeling
44. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1
45. Receptors for advanced glycosylation endproducts in human brain: Role in brain homeostasis
46. RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides
47. Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy
48. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers
49. Cloning and expression of RAGE: A cell surface receptor for advanced glycosylation end products of proteins
50. Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors
51. Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction
52. Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK 1
53. Activation of the receptor for advanced glycation endproducts triggers a MAP kinase pathway regulated by oxidative stress
54. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmatic domain of the receptor but different downstream signaling pathways
55. Activation of the NADPH oxidase involves the sm GTP-binding protein p 21rac1
56. Characterization and isolation of a c-reactive protein receptor from the human monocytic cell line U- 937
57. C-reactive protein receptors on the human monocytic cell line U-937: Evidence for additional binding to FcγRI